Assessment of the global burden and epidemiologic trends of fungal diseases is critical to
prioritizing prevention strategies, diagnostic modalities, and therapeutic interventions. The …

Recent discoveries introduce several potentially novel diagnostic and therapeutic
modalities, which are likely to improve management and outcome for mucormycosis. Future …

Efficient synthetic procedures for the preparation of acid hydrazines and hydrazides were
developed by converting the corresponding carboxylic acid into the methyl ester catalyzed …

To review invasive aspergillosis (IA) in developing countries, we included those countries,
which are mentioned in the document of the International Monetary Fund (IMF), called the …

An online survey of mycology laboratories in seven Asian countries was conducted to
assess the status, competence, and services available. Country representatives from the …

Fungal rhinosinusitis (FRS), once considered a rare disease, has seen a steep rise in
incidence in recent times. This global rise in the burden of fungal disease is a consequence …

The COVID-19 survivors and long-term steroid administered patients exhibit a variety of
fungal co-infections. The lives of COVID-19 patients and survivors are hampered by fungal …

Opportunistic fungal infections caused by the Candida spp. are the most common human
fungal infections, often resulting in severe systemic infections—a significant cause of …

Clinical hallmarks of mucormycosis infections include the unique susceptibility of patients
with increased available serum iron, the propensity of the organism to invade blood vessels …

Zearalenone (ZEA) is a toxic metabolite of Fusarium genera that frequently contaminates
cereal grains. India being a tropical country provides suitable conditions for fungal invasion …